232 related articles for article (PubMed ID: 16131571)
1. Autologous and allogeneic stem cell transplantations for poor-risk chronic lymphocytic leukemia.
Gribben JG; Zahrieh D; Stephans K; Bartlett-Pandite L; Alyea EP; Fisher DC; Freedman AS; Mauch P; Schlossman R; Sequist LV; Soiffer RJ; Marshall B; Neuberg D; Ritz J; Nadler LM
Blood; 2005 Dec; 106(13):4389-96. PubMed ID: 16131571
[TBL] [Abstract][Full Text] [Related]
2. Treatment-related mortality and graft-versus-leukemia activity after allogeneic stem cell transplantation for chronic lymphocytic leukemia using intensity-reduced conditioning.
Dreger P; Brand R; Hansz J; Milligan D; Corradini P; Finke J; Deliliers GL; Martino R; Russell N; Van Biezen A; Michallet M; Niederwieser D;
Leukemia; 2003 May; 17(5):841-8. PubMed ID: 12750695
[TBL] [Abstract][Full Text] [Related]
3. Qualitative and quantitative polymerase chain reaction monitoring of minimal residual disease in relapsed chronic lymphocytic leukemia: early assessment can predict long-term outcome after reduced intensity allogeneic transplantation.
Farina L; Carniti C; Dodero A; Vendramin A; Raganato A; Spina F; Patriarca F; Narni F; Benedetti F; Olivieri A; Corradini P
Haematologica; 2009 May; 94(5):654-62. PubMed ID: 19377072
[TBL] [Abstract][Full Text] [Related]
4. Outcomes of Patients With Chronic Lymphocytic Leukemia and Richter's Transformation After Transplantation Failure.
Rozovski U; Benjamini O; Jain P; Thompson PA; Wierda WG; O'Brien S; Burger JA; Ferrajoli A; Faderl S; Shpall E; Hosing C; Khouri IF; Champlin R; Keating MJ; Estrov Z
J Clin Oncol; 2015 May; 33(14):1557-63. PubMed ID: 25847930
[TBL] [Abstract][Full Text] [Related]
5. Stem-cell transplantation for chronic lymphocytic leukemia: the 1999 perspective.
Dreger P; Michallet M; Schmitz N
Ann Oncol; 2000; 11 Suppl 1():49-53. PubMed ID: 10707779
[TBL] [Abstract][Full Text] [Related]
6. Nonmyeloablative allogeneic stem cell transplantation in relapsed/refractory chronic lymphocytic leukemia: long-term follow-up, prognostic factors, and effect of human leukocyte histocompatibility antigen subtype on outcome.
Khouri IF; Bassett R; Poindexter N; O'Brien S; Bueso-Ramos CE; Hsu Y; Ferrajoli A; Keating MJ; Champlin R; Fernandez-Vina M
Cancer; 2011 Oct; 117(20):4679-88. PubMed ID: 21455998
[TBL] [Abstract][Full Text] [Related]
7. Risk-stratified adoptive cellular therapy following allogeneic hematopoietic stem cell transplantation for advanced chronic lymphocytic leukaemia.
Richardson SE; Khan I; Rawstron A; Sudak J; Edwards N; Verfuerth S; Fielding AK; Goldstone A; Kottaridis P; Morris E; Benjamin R; Peggs KS; Thomson KJ; Vandenberghe E; Mackinnon S; Chakraverty R
Br J Haematol; 2013 Mar; 160(5):640-8. PubMed ID: 23293871
[TBL] [Abstract][Full Text] [Related]
8. Allogeneic stem-cell transplantation may overcome the adverse prognosis of unmutated VH gene in patients with chronic lymphocytic leukemia.
Moreno C; Villamor N; Colomer D; Esteve J; Martino R; Nomdedéu J; Bosch F; López-Guillermo A; Campo E; Sierra J; Montserrat E
J Clin Oncol; 2005 May; 23(15):3433-8. PubMed ID: 15809449
[TBL] [Abstract][Full Text] [Related]
9. High incidence of chronic graft-versus-host disease after myeloablative allogeneic stem cell transplantation for chronic lymphocytic leukemia in Sweden: graft-versus-leukemia effect protects against relapse.
Machaczka M; Johansson JE; Remberger M; Hallböök H; Lazarevic VLj; Wahlin BE; Omar H; Wahlin A; Juliusson G; Kimby E; Hägglund H
Med Oncol; 2013 Dec; 30(4):762. PubMed ID: 24214180
[TBL] [Abstract][Full Text] [Related]
10. Predictors of improved progression-free survival after nonmyeloablative allogeneic stem cell transplantation for advanced chronic lymphocytic leukemia.
Brown JR; Kim HT; Li S; Stephans K; Fisher DC; Cutler C; Ho V; Lee SJ; Milford EL; Ritz J; Antin JH; Soiffer RJ; Gribben JG; Alyea EP
Biol Blood Marrow Transplant; 2006 Oct; 12(10):1056-64. PubMed ID: 17084369
[TBL] [Abstract][Full Text] [Related]
11. Comparable outcome after haploidentical and HLA-matched allogeneic stem cell transplantation for high-risk acute myeloid leukemia following sequential conditioning-a matched pair analysis.
Doppelhammer M; Fraccaroli A; Prevalsek D; Bücklein V; Häbe S; Schulz C; Hubmann M; Hausmann A; Claus R; Rank A; Schmid C; Tischer J
Ann Hematol; 2019 Mar; 98(3):753-762. PubMed ID: 30617644
[TBL] [Abstract][Full Text] [Related]
12. Allogeneic hematopoietic stem-cell transplantation for chronic lymphocytic leukemia with 17p deletion: a retrospective European Group for Blood and Marrow Transplantation analysis.
Schetelig J; van Biezen A; Brand R; Caballero D; Martino R; Itala M; García-Marco JA; Volin L; Schmitz N; Schwerdtfeger R; Ganser A; Onida F; Mohr B; Stilgenbauer S; Bornhäuser M; de Witte T; Dreger P
J Clin Oncol; 2008 Nov; 26(31):5094-100. PubMed ID: 18711173
[TBL] [Abstract][Full Text] [Related]
13. Stem-cell transplantation in children with acute lymphoblastic leukemia: A prospective international multicenter trial comparing sibling donors with matched unrelated donors-The ALL-SCT-BFM-2003 trial.
Peters C; Schrappe M; von Stackelberg A; Schrauder A; Bader P; Ebell W; Lang P; Sykora KW; Schrum J; Kremens B; Ehlert K; Albert MH; Meisel R; Matthes-Martin S; Gungor T; Holter W; Strahm B; Gruhn B; Schulz A; Woessmann W; Poetschger U; Zimmermann M; Klingebiel T
J Clin Oncol; 2015 Apr; 33(11):1265-74. PubMed ID: 25753432
[TBL] [Abstract][Full Text] [Related]
14. Allogeneic hematopoietic stem cell transplant with reduced-intensity conditioning for chronic lymphocytic leukemia in Sweden: does donor T-cell engraftment 3 months after transplant predict survival?
Machaczka M; Johansson JE; Remberger M; Hallböök H; Malm C; Lazarevic VLj; Wahlin A; Omar H; Juliusson G; Kimby E; Hägglund H
Leuk Lymphoma; 2012 Sep; 53(9):1699-705. PubMed ID: 22335529
[TBL] [Abstract][Full Text] [Related]
15. Transplantation in chronic lymphocytic leukemia.
Le Dieu R; Gribben JG
Curr Hematol Malig Rep; 2007 Feb; 2(1):56-63. PubMed ID: 20425389
[TBL] [Abstract][Full Text] [Related]
16. The role of stem-cell transplantation in chronic lymphocytic leukemia risk-adapted therapy.
Giné E; Moreno C; Esteve J; Montserrat E
Best Pract Res Clin Haematol; 2007 Sep; 20(3):529-43. PubMed ID: 17707838
[TBL] [Abstract][Full Text] [Related]
17. Donor Killer Cell Immunoglobulin-Like Receptor Genotype Does Not Improve Graft-versus-Leukemia Responses in Chronic Lymphocytic Leukemia after Unrelated Donor Transplant: A Center for International Blood and Marrow Transplant Research Analysis.
Bachanova V; Weisdorf DJ; Wang T; Marsh SGE; Cereb N; Haagenson MD; Spellman SR; Lee SJ; Guethlein LA; Parham P; Miller JS; Cooley SA
Biol Blood Marrow Transplant; 2019 May; 25(5):949-954. PubMed ID: 30594542
[TBL] [Abstract][Full Text] [Related]
18. Outcomes of allogeneic haematopoietic stem cell transplantation from HLA-matched and alternative donors: a European Society for Blood and Marrow Transplantation registry retrospective analysis.
Shouval R; Fein JA; Labopin M; Kröger N; Duarte RF; Bader P; Chabannon C; Kuball J; Basak GW; Dufour C; Galimard JE; Polge E; Lankester A; Montoto S; Snowden JA; Styczynski J; Yakoub-Agha I; Mohty M; Nagler A
Lancet Haematol; 2019 Nov; 6(11):e573-e584. PubMed ID: 31477550
[TBL] [Abstract][Full Text] [Related]
19. Comparable Long-Term Outcome after Allogeneic Stem Cell Transplantation from Sibling and Matched Unrelated Donors in Patients with Acute Myeloid Leukemia Older Than 50 Years: A Report on Behalf of the Acute Leukemia Working Party of the European Society for Blood and Marrow Transplantation.
Shimoni A; Labopin M; Savani B; Byrne M; Volin L; Finke J; Niederwieser D; Ehninger G; Blaise D; Beelen D; Tabrizi R; Sengeloev H; Ganser A; Cornelissen JJ; Mohty M; Nagler A
Biol Blood Marrow Transplant; 2019 Nov; 25(11):2251-2260. PubMed ID: 31271887
[TBL] [Abstract][Full Text] [Related]
20. Long-term follow-up of patients with CLL treated with allogeneic hematopoietic transplantation.
Khouri IF; Keating MJ; Saliba RM; Champlin RE
Cytotherapy; 2002; 4(3):217-21. PubMed ID: 12194718
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
